Orgenesis Inc. Files 8-K on Material Agreement

Ticker: ORGS · Form: 8-K · Filed: Sep 16, 2025 · CIK: 1460602

Orgenesis INC. 8-K Filing Summary
FieldDetail
CompanyOrgenesis INC. (ORGS)
Form Type8-K
Filed DateSep 16, 2025
Risk Levelmedium
Pages3
Reading Time4 min
Key Dollar Amounts$1,000,000, $250,000, $10,000,000, $7,083,857, $6,083,857
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, financial-obligation

TL;DR

Orgenesis Inc. just signed a big deal and took on debt. Details to follow.

AI Summary

On September 16, 2025, Orgenesis Inc. filed an 8-K report detailing a material definitive agreement and the creation of a direct financial obligation. The filing indicates a significant event for the company, though specific details of the agreement and obligation are not provided in this excerpt.

Why It Matters

This filing signals a new material definitive agreement and a direct financial obligation for Orgenesis Inc., which could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement and a direct financial obligation, which inherently carries financial risk for the company.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Orgenesis Inc.?

The provided excerpt does not specify the details of the material definitive agreement.

What is the direct financial obligation created by Orgenesis Inc.?

The excerpt states the creation of a direct financial obligation but does not provide its specifics.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on September 16, 2025.

In which state is Orgenesis Inc. incorporated?

Orgenesis Inc. is incorporated in Nevada.

What is the business address of Orgenesis Inc.?

The business address is 20271 Goldenrod Lane, Germantown, MD 20876.

Filing Stats: 939 words · 4 min read · ~3 pages · Grade level 12 · Accepted 2025-09-16 17:29:47

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: September 16, 2025 By: /s/ Vered Caplan Vered Caplan Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing